Type IIA Secreted Phospholipase A2 in Host Defense against Bacterial Infections
Publication date
2020-04
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
The enzyme type IIA secreted phospholipase A2 (sPLA2-IIA) is crucial for mammalian innate host defense against bacterial pathogens. Most studies have investigated the role of sPLA2-IIA in systemic bacterial infections, identifying molecular pathways of bacterial resistance against sPLA2-IIA-mediated killing, and providing insight into sPLA2-IIA mechanisms of action. Sensitization of (antibiotic-resistant) bacteria to sPLA2-IIA action by blocking bacterial resistance or by applying sPLA2-IIA to treat bacterial infections might represent a therapeutic option in the future. Because sPLA2-IIA is highly expressed at mucosal barriers, we also discuss how sPLA2-IIA is likely to be an important driver of microbiome composition; we anticipate that future research in this area may bring new insights into the role of sPLA2-IIA in health and disease.
Keywords
antimicrobial enzyme, bacteria, infections, microbiome, phospholipase, virulence, Taverne, Immunology and Allergy, Immunology, Review, Journal Article
Citation
van Hensbergen, V P, Wu, Y, van Sorge, N M & Touqui, L 2020, 'Type IIA Secreted Phospholipase A2 in Host Defense against Bacterial Infections', Trends in immunology, vol. 41, no. 4, pp. 313-326. https://doi.org/10.1016/j.it.2020.02.003